HPV - From Warts to Cancer
|
|
- Emmeline McGee
- 5 years ago
- Views:
Transcription
1 12/26/217 HPV Infection Immunizing for Cancer Prevention Paul J Carson, MD, FACP Professor, Dept. of Public Health North Dakota State University Epidemiology and Pathology HPV Genotypes and Their Disease Associations HPV Epidemiology Mucosal/Genital sites of infection Cutaneous sites of infection ~ 8 types 79 million persons infected in U.S. with 14 million new infections per year 5-7% of sexually active adults infected by age 5 High risk (oncogenic) 16, 18, 31, 33, 45, 52, 58, 35, 39, 51, 56, 59, 68 Cervical, anogenital, and OP cancers, CIS and ACIS Low risk (non-oncogenic) 6, 11 Genital warts, Laryngeal papillomas, Low grade cervical dz Common hand and foot warts 9% women will clear by 2 years, 1% will have prolonged infection 45% of men age are infected (NHANES ), infxn much more likely to persist Han et al. JAMA Onc 217 Contrast HPV Incidence with Other Common STIs Cumulative Incidence of HPV Infection in College Women After Time from 1 st Intercourse Source: CDC 1
2 12/26/217 HPV Prevalence Common in Females Prior to Vaccine, Especially in Early 2s Cumulative Incidence of Genital HPV Infection in Male University Students, Prevalence, % 6 Low-risk HPV* 5 High-risk HPV* Age National Health and Nutrition Examination Survey, HPV Prevalence Among Males Age 18-59: NHANES HPV - From Warts to Cancer HPV Prevalence (%) Normal Cervix CIN I CIN II Any HPV High Risk HPV 9v vaccine strain of HPV Oral Oncogenic HPV CIN III CIN III Invasive Cancer Chaturvedi, Cancer Res 215. Han, JAMA Oncol 217. Estimated Average Annual Number of Cancers Attributable to HPV By Anatomic Site - U.S., HPV Vaccine - Not Just for Girls 18, 16, 14, 12, 1, 8, 6, 4, 2, 83% males One will get HPV Infection, and will be just as likely to develop a cancer as a female 9v Vaccine Type Non HPV or Non Vaccine Type Viens, MMWR
3 12/26/217 HPV, Oral Cancer, and Men Incidence of HPV(+) vs HPV(-) Tonsillar Cancer in Sweden HPV associated OP 5x > men than women) Appears to be associated with oral sexual behavior and number of lifetime partners 22x Increased Risk for OP Cancer in Men Estimated 7.1 million men with oral oncogenic HPV infection in U.S. 7x HPV-16 Other Oncogenic HPV Chaturvedi, Cancer Res 215. D Souza, JID 29. D Souza, JID 216. Agalliu, JAMA Oncol 216. Estimated Annual Burden of HPV- Related Diagnoses in the United States HPV Will Affect Far More of Your Patients than Meningococcal Infection and Hib Combined Vaginal cancer ~2,2 1,2 4, 35, 38,795 Vulvar cancer Anal cancer ~2,115 1,2 ~6,35 1,2,a 3, 25, Pre-Vaccine Era Annual Incidence Cervical cancer ~12,34 1,2 High-grade cervical dysplasia ~28,5 2,3 Genital warts ~5, 1,, 2,4,a Low-grade cervical dysplasia ~1.1 million 2,3 Case counts for HPV-related diagnoses relate to approximately 4 HPV types, not just HPV 6, 11, 16, and 18. Includes cases in both men and women 2, 15, 1, 5, 3, 15, Meningococcal Infection Invasive Hib HPV Related Cancers Lifetime Risk of HPV-Related Pathology Event Risk of Cervical HPV Infection CIN 1 CIN 2/3 or AIS Cervical Cancer Without Pap Testing With Pap Testing Risk of Genital Warts (Men and Women) Risk of Oral HPV Infection Risk (Ratio) 1 in 2 1 in 6 1 in 25 1 in 31 1 in in 8 1 in 2 The Vaccine CDC Fact Sheet, May-24. Ho et al. NEJM American Cancer Society: Cancer Facts and Figures 25. CIN = Cervical Intraepithelial Neoplasia; AIS = Adenocarcinoma in situ. 3
4 12/26/217 Prophylactic HPV Vaccines: L1 Virus-like Particles (VLPs) Non-infectious Produce higher levels of Abs than natural infection HPV Vaccine: What Does it Cover Valency Year Licensed Strains covered Prevents Quadrivalent 26 6, 11, 16, 18 7% Cervical Cancers 9% Genital Warts Bivalent 27 16, 18 7% Cervical Cancers 9-Valent 214 6, 11, 16, 18, 31, 33, 45, 52, 58 9% Cervical Cancers 9% Genital Warts HPV-Associated Cancers by Serotypes in 9-Valent Vaccine Cancer Type 16, 18 31, 33, 45, 52, 58 Total Covered Cervical 66-7% 15-2% 81-9% Vaginal 55% 18% 73% Vulvar 49% 14% 63% Anal (M) 79% 4% 83% Anal (F) 8% 11% 91% Penile 48% 9% 57% Oropharyngeal (M) 63% 4% 67% Oropharyngeal (F) 51% 9% 6% HPV Vaccine: Who Gets it and When HPV Vaccination Timeline Females Males Earliest dose 9 9 Recommended 1 st dose Catch-up Period Permissive -- Up to 26 2 doses: if start before 15 th b-day (, 6-12 mo, ok if > 5 mos) Schedule Special populations: Pregnancy: not recommended limited data Pre-existing cervical abnormality: recommended Immunosuppressed: 3 doses for severe immunosuppression 3 doses (, 1-2, 6 mo) if started on or after 15 b-day or if immunosuppressed 6 months months If started prior to 15 th birthday 7 months Dobson, JAMA 213 4
5 12/26/217 Efficacy of the quadrivalent vaccine against clinical endpoints among women aged in per protocol efficacy population Vaccine Efficacy Clinical endpoint Vaccine No. of women No. of cases Placebo No. of women No. of cases HPV 16/18-related CIN 2/3 OR AIS 8,847 8,46 53 HPV 6/11/16/18-related VIN 2/3 7,897 7,899 8 Vaccine efficacy % (95% CI) 1% (92.9, 1) 1% (41.4, 1) HPV 6/11/16/18-related ValN 2/3 7,897 7,899 5 HPV 6/11/16/18-related genital warts (condyloma) 7, , % (<, 1) 98.9% (93.7, 1) Average duration of follow up was years Falling Rates of Oncogenic HPV in yo Sexually Active Females in England HPV Vaccination Impact on Genital Warts in Young Australian Men and Women HPV 16/18 Prevalence (%) (pre-immunization) (2-3 yrs post-immunization) (4-5 yrs post-immunization) Herd immunity seen for males BMJ (Ali et al., 213) Evidence for Herd Protection from HPV Vaccine 4vHPV Infection among sexually active women age in three eras: Percent Prevalence Unvaccinated women Vaccinated women Pre-vaccine Era Early-vaccine Era Recent-vaccine Era Vaccine Coverage Oliver S. CDC Epidemic Intelligence Service Conference,
6 12/26/217 North Dakota and U.S. Adolescent (Age 13-17) HPV Vaccination Rates (215 NIS) North Dakota Adolescent (13-17) Immunization Rates (NIS) % Vaccinated HPV1-Female HPV3-Female HPV1-Male HPV3-Male U.S. North Dakota Healthy People 22 Goal for HPV3 Tdap MCV4 Female 1 dose HPV Female 3 doses HPV Male 1 dose HPV Male 3 doses HPV Actual and Potentially Achievable Vaccination Coverage with >1 Dose HPV in 13 yo Girls if Missed Opportunities Eliminated Barriers to Vaccination MMWR July 215 Parental Attitudes Towards HPV Vaccination % Mandating vaccine is a bad idea Vaccine might cause lasting health problems Vaccine being pushed to make money for drug companies Calo et al. Cancer Epi, Biomarkers & Prevent, 216 6
7 12/26/217 Reasons Parents Don t Vaccinate Against HPV Top five reasons for not vaccinating adolescents with human papillomavirus (HPV) vaccine* - National Immunization Survey-Teen, United States, 213 Parents of girls Parents of boys Reason % (95% CI) Reason % (95% CI) Lack of knowledge 15.5 ( ) Not recommended 22.8 ( ) Not needed or necessary 14.7 ( ) Not needed or necessary 17.9 ( ) Safety concern/side effects 14.2 ( ) Lack of knowledge 15.5 ( ) Not recommended 13. ( ) Not sexually active 7.7 ( ) Not sexually active 11.3 ( ) Safety concern/side effects 6.9 ( ) *Analysis limited to parents reporting that they were not likely to seek HPV vaccination for their teen in the next 12 months or were unsure of their HPV vaccination plans. Quality of Physician Communication About HPV Vaccine 1:2 Women Graduating from College Will Acquire HPV, Can You Guess Which One? National survey of 776 pediatricians and family physicians 1 Up to 27% do not strongly endorse 26% do not recommend at age for girls and 39% do not for boys Only 51% usually recommended same-day vaccination 59% used a risk-based approach to recommend HPV vaccine 1/3 of FPs reported little or no confidence in pre-licensure vaccine safety studies 2 5% Only 4% of 928 respondents of a national sample of Peds/FPs/Obs reported always recommending HPV vaccine to female patients age yo, 55% for yo 3 Gilkey MB. Cancer Epi Biomarkers Prev 215 O Leary ST. Prev Med 213 Vadaparampil ST. Am J Prev Med 214 HPV Vaccine -What Are the Concerns? Why give it so young? Does it tacitly approve/promote premarital or promiscuous sex? Safety Concerns 7
8 12/26/217 HPV Vaccine -What Are the Concerns? Why give it so young? Does it tacitly approve/promote premarital sex? Safety Concerns Rationale for Vaccinating Appropriate 11- or 12-Year-Olds (continued) 1 A national survey of adolescents and young adults age years (N=1552) focused on their sexual health knowledge, attitudes, and experiences; these data reflect 114 participants who reported an initial sexual intercourse encounter. HPV=human papillomavirus. 1. Hoff T et al. National Survey of Adolescents and Young Adults: Sexual Health Knowledge, Attitudes and Experiences. Henry J. Kaiser Family Foundation; 23. Adapted by the author(s) from " National Survey of Adolescents and Young Adults: Sexual Health Knowledge, Attitudes and Experiences, (#3218), The Henry J. Kaiser Family Foundation, May 23. This information was reprinted with permission from the Henry J. Kaiser Family Foundation. Younger Vaccinees Mount Better Antibody Responses HPV Vaccine -What Are the Concerns? Plots of month 7 humoral responses in females to component human papillomavirus (HPV) vaccine types, by age at enrolment GMT 1mo after 3 rd Dose of HPV-2 2.2x Why give it so young? Does it tacitly approve/promote premarital sex? Safety Concerns 1 1.7x y.o y.o. Anti HPV-16 Anti HPV-18 Anna R. Giuliano et al. J Infect Dis. 27;196:
9 12/26/217 Subsequent Sexual Behavior in Vaccinated vs Unvaccinated Females HPV Vaccine -What Are the Concerns? Author / Yr N Country Measured Outcome Group difference Why give it so young? Does it tacitly approve/promote premarital sex? Anupam ,111 USA Incidence of STIs No difference Hansen ,786 Denmark, Norway, Sweden Smith ,493 Canada Bednarczyk 212 1,398 USA Age at first intercourse, Number of sexual partners Incidence of STIs and Pregnancy in adolescent girls pre and post HPV introduction Pregnancy, Contraception counseling, STI infx/counseling No difference No difference No difference Safety Concerns HPV Vaccine Safety From June 26-March 216, ~ 9 million doses of HPV vaccine given in U.S., > 2 million doses worldwide Clinical licensure trials: Increased incidence of sore arm, lightheadedness VAERS: 33,945 reports filed, 92% not serious, 7% serious. Fainting, dizziness, nausea, headache, fever, hives, localized pain most common 96 deaths no pattern and no connection to vaccine found Post-Licensure Safety Trials for HPV Vaccination Author / Year N Country Slade, 29 12,424 U.S. Type of Study Case Report Analysis Klein, ,625 U.S. Cohort Measured Outcome VAERS Severe Adverse Events Emergency department visits and hospitalizations Group Difference Increased Syncope and DVT Increased syncope and local skin infections, no SAEs Scheller, 214 1,613,798 Denmark Case-Control Incidence rate of venous thromboembolism No difference Arnheim- Denmark, 997,585 Dahlström, 213 Sweden Cohort Incidence of autoimmune dz, neurological, and thromboembolic events No difference Chao, ,629 U.S. Cohort Incidence of autoimmune conditions No difference Huygen, ,391 Worldwide Scheller, 215 3,983,824 Denmark Sweden Case Report Analysis Mølbak, ,226 Denmark Case-Control Complex Regional Pain Syndrome No association Case-Control Multiple sclerosis No difference Pre-vaccination care-seeking in females reporting SAEs Increased OR Strategies to Improve HPV Vaccine Acceptance What can we do to Improve? Three pronged communication approach based on the best evidence to date: 1. Announce 2. EASE the main concern 3. Recommend 9
10 12/26/217 How You Frame the Question Study Cross-sectional observational study of pediatrician-parent discussions at well-child visits around topic of vaccination Study described to providers and parents only in general terms re: communication Vaccination Today?? Parents assessed on prior survey for degree of vaccine hesitancy, over-sampled vaccine-hesitant parents Video camera recorded the encounter in the pediatrician s exam room Communications experts assessed the manner in which conversation was initiated Opel D. Pediatrics 213 Adolescent Vaccination Uptake by Communication Style Summary: Framing the Question and Pursuit Presume Acceptance 74% Pursue Pursue 12% 2% = 88% accept 5% offer mitigated plan 7% reject immunization ** 1 9 ** * * p <.5 ** p <.1 8 ** 7 Participate Acceptance Pursue 4% = 21% 25% accept 42% offer mitigated plan 33% resist immunization Participate Acceptance Acquiesce 4% % = 4% accept 13% offer mitigated plan 83% resist immunization 2 1 Tdap Opel D. Pediatrics 213 Announcements Meng Informed Shared HPV Efficient Moss JL. Soc Sci & Med 216 Improving HPV Vaccine Acceptance Announcements vs Conversation Conversation 16 % Increase at 6 mos vs 14 N = 29 clinics, 17,173 children p = Control Conversation Announcements Brewer et al. Pediatrics
11 12/26/217 Normalize HPV Vaccination: Sandwich Between the Routine Vaccines Announce Example Tdap HPV I see here that Michael just turned 11. Because he s 11, Michael is due for meningitis, HPV, and Tdap vaccines. We ll give those at the end of today s visit. Now that Michael is 12, there are three vaccines we give to kids his age. Today, he ll get meningitis, HPV, and Tdap vaccines. Meningococcus EASE the Main Concern Example: EASE the Main Concern Elicit main concern about the vaccine Ask the parent to be specific, is this the main concern? Acknowledge the main concern Important to say you understand why they have this concern Share your commitment You and the parent are together on wanting what is best for the child, show how you keep up to date on information needed for child s care Educate on what research shows in every day language to address concern Elicit. What s your main concern about HPV vaccine? I think we can wait until Bianca is a little older, don t you? Acknowledge. I get it, Bianca is young, I can see why you may be worried that she isn t ready for HPV vaccine. Share your commitment. The safety and necessity of these vaccines is something I take very seriously in my practice. Because preventive care for kids Bianca s age is important to me, I keep up-to-date on vaccine studies and I follow CDC guidelines for vaccination. Educate on what research shows. Children Bianca s age should get HPV vaccine because younger children develop better protection. We want her to get the vaccine far before she is exposed to an infection that could lead to cancer. HPV vaccine is cancer prevention. Make a Strong Recommendation, Emphasize Benefits of Vaccination On Schedule I highly recommend getting this vaccine today, my kids are vaccinated One of only 2 vaccines we have that prevent cancer! If vaccination done at yo visit, only 2 doses (one less shot, one less clinic visit)! If done at younger age, much better vaccine response and likelihood of protection! Our boys need this as much as our girls? Possibility of non-sexual transmission, or future infected spouse 11
12 12/26/217 12
Improving HPV Vaccine Coverage In North Dakota By Enhancing Adolescent AFIX
Improving HPV Vaccine Coverage In North Dakota By Enhancing Adolescent AFIX North Dakota and U.S. Adolescent (Age 13-17) HPV Vaccination Rates (2015 NIS) 80 % Vaccinated 70 60 50 40 30 20 10 U.S. North
More information9/11/2018. HPV Yoga. Human Papillomavirus. Human Papillomavirus (HPV) Disease. Most common sexually transmitted infection in the U.S.
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Human Papillomavirus September 2018 Chapter 11 Photographs and images included in this presentation
More informationHPV Prevention: Where Are We and Where Do We Need to Go. Rachel Caskey, MD MAPP
HPV Prevention: Where Are We and Where Do We Need to Go Rachel Caskey, MD MAPP Assistant Professor of Internal Medicine and Pediatrics University of Illinois at Chicago Disclosures I have no financial
More informationHPV Vaccination: A Missed Opportunity for Cancer Prevention. New Developments in Objectives for today s talk
HPV Vaccination: A Missed Opportunity for Cancer Prevention Kevin A. Ault, MD Tuesday, July 26, 2016 New Developments in 2015-16 a second generation polyvalent HPV became available for use in 2015 HPV
More informationYou are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Successfully
You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Successfully Communicating about HPV Vaccination Disclosure This
More informationDe-Sexualizing the HPV Vaccine How to Counsel Your Families
De-Sexualizing the HPV Vaccine How to Counsel Your Families Laura J. Benjamins, MD, MPH Assistant Professor, Adolescent Medicine The University of Texas Medical School, Houston Objectives Understand current
More informationCervical Cancer The Role of Primary Care in Reducing Cancer Disparities
Cervical Cancer The Role of Primary Care in Reducing Cancer Disparities March 28, 2015 Electra D. Paskett, Ph.D. The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and
More informationYou are the Key to HPV Cancer Prevention Communicating about HPV Vaccination
You are the Key to HPV Cancer Prevention Communicating about HPV Vaccination Jill B Roark, MPH Carter Consulting Inc. Health Communication Specialist Janine Cory MPH Senior Health Communication Specialist
More informationWednesday, March 16, 2016
You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about HPV Vaccination Bea Himmelwright-Lamm, EdD, RN
More informationEvidence-Based HPV Disease Prevention HPV VACCINE
Evidence-Based HPV Disease Prevention HPV VACCINE Educating and normalizing vaccine compliance for the teen population Leisha Nolen, MD PhD Enroll in Electronic Poll System In the texting app in your phone:
More informationAn update on the Human Papillomavirus Vaccines. I have no financial conflicts of interest. Case 1. Objectives 10/26/2016
An update on the Human Papillomavirus Vaccines Karen Smith-McCune Professor, UCSF Department of Obstetrics, Gynecology and Reproductive Sciences John Kerner Endowed Chair I have no financial conflicts
More informationHPV Cancer Prevention
MiCMRC Educational Webinar HPV Cancer Prevention September 20, 2017 MiCMRC Care Management Educational Webinar: You are the Key to HPV Cancer Prevention Expert Presenter: Abby Moler Sr. Manager, Primary
More informationSharon G. Humiston, MD, MPH, FAAP Professor of Pediatrics Children s Mercy Hospital Kansas City, MO
Sharon G. Humiston, MD, MPH, FAAP Professor of Pediatrics Children s Mercy Hospital Kansas City, MO Topic #1 HPV disease causes loss of lives and plenty of misery. HPV vaccine prevents this. https://www.cdc.gov/hpv/hcp/more-than-screening/infographic.html
More informationHPV FREE IDAHO. Fundamentals of HPV Bill Atkinson, MD MPH
HPV FREE IDAHO Fundamentals of HPV Bill Atkinson, MD MPH You are the Key to HPV Cancer Prevention William Atkinson, MD, MPH Associate Director for Immunization Education Immunization Action Coalition February
More informationAt the completion of this activity, participants will be better able to : 72 years (women) Pseudovirion based vaccines.
At the completion of this activity, participants will be better able to : 1. Assess the potential effect of HPV infection 2. Identify HPV serotypes associated with particular cancers and genital warts
More informationHPV-Associated Disease and Prevention
HPV-Associated Disease and Prevention Odessa Regional Medical Center May 28, 2015 Erich M. Sturgis, MD, MPH Professor Department of Head & Neck Surgery Department of Epidemiology Christopher & Susan Damico
More informationHPV Vaccine Ina Park, MD, MS
HPV Vaccine Ina Park, MD, MS California Department of Public Health STD Control Branch Alameda County Immunization Update 2014 Over 170 types of HPV classified Updated incidence/prevalence estimates (CDC):
More informationYou are the Key to HPV Cancer Prevention
AHEC Logo here You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about HPV Vaccination Aubrey Stetter-Hesselberg,
More informationRaising HPV Immunization Rates Through Provider Education. Objectives HPV INFECTION & DISEASE 8/2/2018. Understanding the Burden
Raising HPV Immunization Rates Through Provider Education Mary Koslap Petraco DNP, PNP BC, CPNP, FAANP Adjunct Clinical Assistant Professor Stony Brook School of Nursing Nurse Consultant Immunization Action
More informationHPV/Cervical Cancer Resource Guide for patients and providers
DHS: PUBLIC HEALTH DIVISION IMMUNIZATION PROGRAM HPV/Cervical Cancer Resource Guide for patients and providers Independent. Healthy. Safe. Oregon HPV Provider Resource Kit: Table of Contents Provider Information
More informationHPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION
National Center for Immunization & Respiratory Diseases HPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION Melinda Wharton, MD, MPH Director, Immunization Services Division Mississippi Primary Health
More informationPresenter Disclosure Information
1:30 2:25pm An Update on HPV Cancer Prevention SPEAKERS Kenneth Alexander, MD, PhD Anna Giuliano, PhD Presenter Disclosure Information The following relationships exist related to this presentation: Dr
More informationHPV is ubiquitous. Skin-to-Skin Contact. Most will not develop cancer. By age 50, 80% of women will have acquired a genital HPV infection
Worldwide, HPV causes ~5% of all new cancers occurring in males and females annually Globally, HPVs are responsible for: Virtually 100% of cervical cancers 70% of vaginal cancers 43% of vulvar cancers
More informationHPV in the U.S.- Where are we now?
HPV in the U.S.- Where are we now? Heather M. Limper, MPH, PhD Candidate hlimper@medicine.bsd.uchicago.edu Conflicts of Interest I have no disclosures to make of any conflicts of interest associated with
More informationHuman Papillomavirus Lafayette Medical Education Foundation June 19, 2018
Human Papillomavirus Lafayette Medical Education Foundation June 19, 2018 Katherine McHugh, MD Indiana University Dept. of OB/GYN kwmchugh@iupui.edu Take Home Points: - Risk factors for HPV infection:
More informationThe HPV Vaccine: A Sheep in Wolf's Clothing
The HPV Vaccine: A sheep in wolf s clothing Jessica Francis, MD Medical College of Wisconsin Nothing to disclose Disclosures Objectives To review the effects of HPV To review recommendations regarding
More informationHPV Vaccination Rates
HPV Vaccination Rates Jennifer E. Dietrich MD, MSc Fellowship Director Pediatric and Adolescent Gynecology, Division of Pediatric and Adolescent Gynecology Department of Obstetrics and Gynecology Department
More informationOverview of HPV; Making it Real
Overview of HPV; Making it Real Deanna Kepka, PhD, MPH Cancer Control and Population Sciences, Huntsman Cancer Institute College of Nursing, University of Utah November 19, 2016 Objectives: Provide an
More informationThe Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California
The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California Immunization Coalition, funded through a cooperative agreement
More informationA simple question? If there was a vaccine that could prevent over 30,000 cases of cancer per year*, which would be your biggest worry?
A simple question? If there was a vaccine that could prevent over 30,000 cases of cancer per year*, which would be your biggest worry? How do we make and stock enough vaccine for the overwhelming demand
More informationHPV Trends: Improving Vaccination Coverage
National Center for Immunization & Respiratory Diseases HPV Trends: Improving Vaccination Coverage Cindy Weinbaum MD MPH Acting Director, Immunization Services Division Texas Immunization Conference San
More informationHPV and Cervical Cancer: Current Practice Update
HPV and Cervical Cancer: Current Practice Update Dr. Sheona Mitchell-Foster MD MPH FRCSC Assistant Professor University of British Columbia Fertility and Reproductive Medicine Symposium Disclosures None
More informationHPV doesn t concern men?
Think HPV doesn t concern men? What you should know about HPV-related cancers and genital warts. One infected partner may be all it takes to get HPV. HPV=human papillomavirus Trying to decide if GARDASIL
More informationDisclosures. New ACIP Recommendations for HPV Vaccination. Human Papillomaviruses. Objectives
New ACIP Recommendations for HPV Vaccination Meg Fisher, MD Medical Director Disclosures I have no financial disclosures. I do not plan to discuss off label uses of vaccines. I have borrowed/stolen extensively
More informationYou are the Key to HPV Cancer Prevention Presentation Script
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 You are the Key to HPV Cancer Prevention Presentation Script Hello my name is and I am the at .
More informationMaking the connections Washington families need to be healthy. Preventing HPV Cancers: A Distance-Learning Course in Washington
Making the connections Washington families need to be healthy. Preventing HPV Cancers: A Distance-Learning Course in Washington Why a continuing education course on recommending HPV immunization? HPV immunization
More informationDISCLOSURES. None of the planners or presenters of this session have disclosed any conflict or commercial interest
Latest HPV Science Holly B. Fontenot, PhD, RN, WHNP-BC Assistant Professor, Boston College Director, WHNP Program Adjunct Faculty, The Fenway Institute NP, Fenway Health/Sidney Borum Health Center DISCLOSURES
More informationWelcome to the California Immunization Coalition Education Hour
Welcome to the California Immunization Coalition Education Hour 1 Parents and Providers Partnering to Protect Our Kids from HPV 2 . Webinar Objectives Provide information about HPV, HPV vaccination, recommendations,
More informationDr. Sarah Oliver, MD Pediatrics Rockcastle Regional Hospital July 22, 2016
AHEC Logo here You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about HPV Vaccination Dr. Sarah Oliver,
More informationAddressing HPV Vaccine Hesitancy and Myths. A simple question?
A simple question? If there was a vaccine that could prevent over 30,000 cases of cancer per year*, which would be your biggest worry? How do we make and stock enough vaccine for the overwhelming demand
More informationLearning Objectives 12/9/2015. HPV Vaccine and Provider Parent Communication REFRAMING THE HPV VACCINE JUST ANOTHER SHOT:
From the MINNESOTA Department of Health HTTPS://WWW.YOUTUBE.COM/WATCH?V=VFHJK5L0T Y JUST ANOTHER SHOT: REFRAMING THE HPV VACCINE HPV Vaccine and Provider Parent Communication Sharon Humiston, MD, MPH,
More informationThe mission of the American School Health Association is to transform all schools into places where every student learns and thrives.
title Subtitle The mission of the American School Health Association is to transform all schools into places where every student learns and thrives. The American School Health Association envisions healthy
More information2017 Human Papillomavirus Immunisation Programme
2017 Human Papillomavirus Immunisation Programme 1 1 HPV infection HPV is a virus that infects the skin and mucous membranes Most infections clear within 18 months Clearing infection does not confer immunity
More informationMake the CASE FOR PHARMACISTS ONLY. Helpful information for talking to parents about HPV vaccination
FOR PHARMACISTS ONLY Make the CASE Helpful information for talking to parents about HPV vaccination Indication GARDASIL 9 is a vaccine indicated in females 9 through 26 years of age for the prevention
More informationApril Blackmon NURS7440/7550. Gardasil. Auburn University/Auburn Montgomery
April Blackmon Health Promotion Paper NURS7440/7550 Gardasil Auburn University/Auburn Montgomery 2 Introduction Human papillomavirus or HPV is a virus that will affect an estimated 75%- 80% of males and
More informationSCCPS Scientific Committee Position Paper on HPV Vaccination
SCCPS Scientific Committee Position Paper on HPV Vaccination Adapted from Joint Statement (March 2011) of the: Obstetrical & Gynaecological Society of Singapore (OGSS) Society for Colposcopy and Cervical
More informationCommunicating about HPV vaccination: Lessons learned from physicians and parents
Communicating about HPV vaccination: Lessons learned from physicians and parents Melissa B. Gilkey, PhD Assistant Professor of Population Medicine Harvard Medical School & Harvard Pilgrim Health Care Institute
More informationBUST MYTHS WITH FACTS
Death too early BUST MYTHS WITH FACTS Awkward Conversation Autism HPV FREE IDAHO HPV FREE IDAHO Myth: The HPV Vaccine is Unsafe Tom Patterson, MD, FAAP, FABD Vaccine Safety HPV FREE IDAHO Safety Monitoring
More informationHuman Papillomavirus (HPV) and Cervical Cancer Prevention
Human Papillomavirus (HPV) and Cervical Cancer Prevention MOA Autumn Convention November 3, 2017 David J Boes, DO, FACOOG (Dist.) Associate Professor, MSU-COM 1 Disclosures None relative to this presentation
More informationThe HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland
The HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland Immunisations Very cost effective intervention Give vaccine before exposure to disease UK has life course approach
More informationWhat You Should Know. Exploring the Link between HPV and Cancer.
What You Should Know Exploring the Link between HPV and Cancer www.indianacancer.org What is HPV? The Human papillomavirus (HPV) is the most common sexually transmitted infection (STI). An STI is a virus
More informationThe Importance of HPV Vaccination and Strategies to Increase Uptake in Pediatric & Family Practices
The Importance of HPV Vaccination and Strategies to Increase Uptake in Pediatric & Family Practices Amanda Dempsey, MD, PhD, MPH Associate Professor of Pediatrics Children s Hospital Colorado October,
More informationReal-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage
Real-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage Prof. Charbell Miguel Haddad Kury, MD Pediatrician Infectious
More informationYOU ARE THE KEY Strategies to Improve HPV Vaccination Rates
YOU ARE THE KEY Strategies to Improve HPV Vaccination Rates West Virginia Rural Health Conference October 17, 2018 Elaine Darling, MPH, Senior Program Manager WV Immunization Network, The Center for Rural
More informationSAGE evidence to recommendations framework i
SAGE evidence to recommendations framework i Question: What is the public health impact on cervical cancer of administering HPV vaccine to 9 to 15-year old females and males versus to 9 to 15-year old
More informationAdvancing HPV Vaccination in Your Practice Jane Pezua, MPH Health Educator Adolescent Immunization Coordinator
Advancing HPV Vaccination in Your Practice Jane Pezua, MPH Health Educator Adolescent Immunization Coordinator California Department of Public Health 1 Objectives Understand burden of HPV disease Describe
More information12/4/18 HPV VACCINATION IN MASSACHUSETTS AND BEYOND VANUCCI DISCLOSURE OBJECTIVES VACCINE BENEFITS VACCINE COMMUNICATION WORLD
HPV VACCINATION IN MASSACHUSETTS AND BEYOND Rebecca Vanucci, MA 6 th Annual HPV-Related Cancer Summit November 30, 2018 1 2 VANUCCI DISCLOSURE OBJECTIVES I, Rebecca Vanucci, have been asked to disclose
More informationHPV Epidemiology and Natural History
HPV Epidemiology and Natural History Rachel Winer, PhD, MPH Associate Professor Department of Epidemiology University of Washington School of Public Health rlw@uw.edu Human Papillomavirus (HPV) DNA virus
More informationGuard Ur Self: HPV and Immunization Education
Guard Ur Self: HPV and Immunization Education MOLLY BE N NIN G, MARCU S G ARCIA, JACQUE LY N SILVE R THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ASHP-SSHP Objectives- Pharmacists 1. Review ACIP updates
More informationUpdate of the role of Human Papillomavirus in Head and Neck Cancer
Update of the role of Human Papillomavirus in Head and Neck Cancer 2013 International & 12 th National Head and Neck Tumour Conference Shanghai, 11 13 Oct 2013 Prof. Paul KS Chan Department of Microbiology
More informationObjectives 1. Become familiar with current immunization schedules for children
Sarah Matches, DO, FAAP Assistant Professor UNTHSC, Dept. of Pediatrics Objectives 1. Become familiar with current immunization schedules for children 2. Describe the international progress in reducing
More informationHuman Papillomavirus (HPV): Vaccine-Preventable Disease
Human Papillomavirus (HPV): Vaccine-Preventable Disease Texas Department of State Health Services (DSHS) Immunization Program, Health Service Region 6/5S Sabrina Stanley, CHES, MPHc Crystal Thomas, MPH
More informationAnal Cancer and HPV Related Tumor Prevention
Anal Cancer and HPV Related Tumor Prevention Timothy J. Wilkin, MD, MPH Associate Professor of Medicine Weill Cornell Medicine New York, New York Learning Objectives After attending this presentation,
More informationHuman Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita
Human Papillomavirus Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita What is Genital HPV Infection Human papillomavirus is
More information1 Cervical Cancer Prevention and Screening: Update 2010 Michael S. Policar, MD, MPH Clinical Professor of Ob, Gyn, and RS UCSF School of Medicine policarm@obgyn.ucsf.edu No commercial disclosures for this
More informationFocus. A case. I have no conflicts of interest. HPV Vaccination: Science and Practice. Collaborative effort with Karen Smith-McCune, MD, PhD 2/19/2010
HPV Vaccination: Science and Practice George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics Director, Colposcopy Clinic,
More informationAdolescent Immunizations
Adolescent Immunizations Preteen Vaccine Week Webinar January 23, 2008 Eileen Yamada, MD, MPH California Department of Public Health Immunization Branch Younger Children AND Adolescents Need Immunizations!
More informationObjectives. Background. Background. Background. Background 9/26/16. Update on Cervical and HPV Screening Guidelines: To pap or not to pap?
Update on Cervical and HPV Screening Guidelines: To pap or not to pap? Marina Delazari Miller MD Clinical Assistant Professor Department of Obstetrics & Gynecology University of Iowa Hospitals and Clinics
More informationDisclosures. Human Papillomaviruses. Objectives. The Second Cancer Vaccine: Human Papillomavirus Vaccine. I have no disclosures.
The Second Cancer Vaccine: Human Papillomavirus Vaccine Meg Fisher, MD Medical Director Disclosures I have no disclosures. I do not plan to discuss off label uses of vaccines. Objectives Discuss the epidemiology
More informationWhat is the Safety and Efficacy of Vaccinating the Male Gender to Prevent HPV Related Neoplastic Disorders in Both the Male and Female Genders
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2011 What is the Safety and Efficacy of Vaccinating
More informationBattle against Human Papilloma Virus (HPV): Expanded Vaccine Recommendations
Battle against Human Papilloma Virus (HPV): Expanded Vaccine Recommendations Sean W. Clark, Pharm.D. PGY-2 Ambulatory Care Resident Duquesne University and The Center for Pharmacy Care I have no relevant
More informationPRODUCT INFORMATION GARDASIL 9. [Human Papillomavirus 9-valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) vaccine, Recombinant]
PRODUCT INFORMATION GARDASIL 9 [Human Papillomavirus 9-valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) vaccine, Recombinant] DESCRIPTION GARDASIL 9 *, Human Papillomavirus 9-valent Vaccine, Recombinant,
More informationWhat Parents Should Know
What Parents Should Know Exploring the Link between HPV and Cancer www.indianacancer.org What is HPV? The Human papillomavirus (HPV) is the most common sexually transmitted infection (STI). An STI is a
More informationSpeaker Name Speaker Title Speaker Affiliation. {Updated August 5, 2014; Replace with date of Presentation}
You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about HPV Vaccination Speaker Name Speaker Title Speaker
More informationQuestions and answers about HPV. Facts about the virus and the vaccine
Questions and answers about HPV Facts about the virus and the vaccine About the introduction of the human papillomavirus (HPV) vaccine Which countries have introduced the HPV vaccine? Over 100 countries
More informationHPV and HPV Vaccine: The Current State of the Research
HPV and HPV Vaccine: The Current State of the Research Robert A. Bednarczyk, PhD May 31, 2018 University of Calgary The O Brien Institute for Public Health and The Department of Community Health Sciences
More informationNatoshia M. Askelson, MPH, PhD Elizabeth T. Momany, PhD Mesay Tegegne Stephanie Edmonds, RN, MPH
Natoshia M. Askelson, MPH, PhD Elizabeth T. Momany, PhD Mesay Tegegne Stephanie Edmonds, RN, MPH This work was supported by Grant IRG-77-004-34 from the American Cancer Society, administered through the
More informationHPV is the most common sexually transmitted infection in the world.
Hi. I m Kristina Dahlstrom, an instructor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. My lecture today will be on the epidemiology of oropharyngeal
More informationThe promise of HPV vaccines for Cervical (and other genital cancer) prevention
The promise of HPV vaccines for Cervical (and other genital cancer) prevention CONTROVERSIES IN OBSTETRICS GYNECOLOGY & INFERTILITY Barcelona March 27 F. Xavier Bosch Catalan Institute of Oncology CURRENT
More informationImproving HPV Vaccine Coverage Why We Must and How We Can Do Better
National Center for Immunization & Respiratory Diseases Improving HPV Vaccine Coverage Why We Must and How We Can Do Better Melinda Wharton, MD, MPH Director, Immunization Services Division Illinois State
More informationCervical Cancer Screening - Improving PAP Rates. Objectives
Cervical Cancer Screening - Improving PAP Rates Dineo Khabele, MD, FACOG, FACS Assistant Professor Division of Gynecologic Oncology Vanderbilt University Medical Center Objectives 1. Review the current
More informationGoals. In the News. Primary HPV Screening 3/9/2015. Your PAP and HPV Update Primary HPV Testing- Screening Intervals- HPV Vaccine Updates-
Your PAP and HPV Update 2015 Connie Mao, MD University of Washington Goals Primary HPV Testing- Is it time to stop doing pap smears? Screening Intervals- Should patients have a choice? HPV Vaccine Updates-
More informationCarolyn Johnston, MD Clinical Professor University of Michigan and St. Joseph Mercy Hospital Gynecologic Oncology Sept 2014
Carolyn Johnston, MD Clinical Professor University of Michigan and St. Joseph Mercy Hospital Gynecologic Oncology Sept 2014 HPV is the most common sexually transmitted infection in the USA Small DNA virus
More informationPractical Strategies to Protect our Community from HPV-related Cancers.
Practical Strategies to Protect our Community from HPV-related Cancers www.immunizeusa.org The Immunization Partnership The Epidemic of HPV Related Cancers in Men: Why We Must Vaccinate Our Boys April
More informationPathology of the Cervix
Pathology of the Cervix Thomas C. Wright Pathology of the Cervix Topics to Consider Burden of cervical cancer 1 Invasive Cervical Cancer Cervical cancer in world Second cause of cancer death in women Leading
More informationPreventive Vaccines against HPV. Paris, 2 April 2015 Yvonne Deleré, MD (former) Immunization Unit, Robert Koch Institute, Berlin
Preventive Vaccines against HPV Paris, 2 April 2015 Yvonne Deleré, MD (former) Immunization Unit, Robert Koch Institute, Berlin Content 1. HPV associated diseases 2. Preventivevaccines Efficacy Safety
More informationImmunization Update: What s New?
Immunization Update: What s New? Joseph A. Bocchini, Jr. MD, FAAP Professor and Chairman Department of Pediatrics Louisiana State University Health Sciences Center Shreveport Red Stick Potpourri LA Chapter-American
More informationSelling Parents on HPV Vaccination for Their Preteens: You Are The Key
Selling Parents on HPV Vaccination for Their Preteens: You Are The Key November 7, 2014 Jill B Roark, MPH Lead, Adolescent Immunization Communications Health Communication Science Office National Center
More informationObjectives. Selling Parents on HPV Vaccination for Their Preteens: You Are The Key. HPV Facts TOP TEN List. Disclosure
11/12/214 Objectives Selling Parents on HPV Vaccination for Their Preteens: You Are The Key November 7, 214 Jill B Roark, MPH Lead, Adolescent Immunization Communications Health Communication Science Office
More informationQuick Reference: Immunization Communication Tool For Immunizers HPV 2010
Quick Reference: Immunization Communication Tool For Immunizers HPV 2010 Are young girls being used as guinea pigs for an unproven vaccine? Client knowledge NO. In both clinical trials conducted for the
More informationObjectives. Disclosures. HPV: Quick Facts
Objectives Identify the prevalence of HPV and HPVrelated malignancies across Texas Understand the impact of HPV vaccination on HPV-malignancies Describe cancer survivors risk for HPVrelated malignancies
More informationRisk Communication and HPV Vaccination: Fixing a Crisis in Cancer Prevention
Risk Communication and HPV Vaccination: Fixing a Crisis in Cancer Prevention Noel T. Brewer, PhD University of North Carolina Twitter: @noeltbrewer Disclosure Grants, speaker or advisory boards American
More informationUICC HPV and CERVICAL CANCER CURRICULUM. UICC HPV and Cervical Cancer Curriculum Chapter 5. Application of HPV vaccines Prof. Suzanne Garland MD
UICC HPV and CERVICAL CANCER CURRICULUM 01 Chapter 5. Application of HPV vaccines Director of Microbiological Research Director of Clinical Microbiology and Infectious Diseases The Royal Women's Hospital
More informationThe HPV Immunisation Programme in NZ. Chris Millar Senior Advisor Immunisation Ministry of Health
The HPV Immunisation Programme in NZ Chris Millar Senior Advisor Immunisation Ministry of Health chris_millar@moh.govt.nz 4 September 2015 Background of NZ s HPV Immunisation Programme Aim: To protect
More informationWhat You Need to Know about Vaccine Safety
What You Need to Know about Vaccine Safety Melinda Wharton, MD, MPH Director, Immunization Services Division National Center for Immunization & Respiratory Diseases Increasing HPV Vaccination in the United
More informationin the United States during the period ACIP to routinely receive HPV vaccination.
Objectives 1. Describe trends in adolescent immunization coverage in the United States during the period 2006 2014. 2. Identify which groups are currently recommended by ACIP to routinely receive HPV vaccination.
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationHuman papillomavirus
2012 Antigen Review for the New Zealand National Immunisation Schedule: Human papillomavirus Auckland UniServices Limited A wholly owned company of The University of Auckland Prepared for: New Zealand
More informationRecommendations for Human Papillomavirus Vaccination Provincial Infectious Diseases Advisory Committee on Immunization
Recommendations for Human Papillomavirus Vaccination Provincial Infectious Diseases Advisory Committee on Immunization June 11, 2012 i This document was prepared for the Provincial Infectious Diseases
More information